Head of CIRM, California’s stem cell research funding agency,to leave mid-month


Millan, a transplant surgeon by training, had been with CIRM since 2012 and its president and CEO since 2017.

Previous Arlington’s Surescripts acquires ActiveRadar to arm doctors with better prescribing data
Next Cone Health launches population genomics project with NIH-backed startup Helix